Company intelligence / Profile preview

Chemicell

Berlin, Germany

Ownership: Private
Development stage: Other

Overview

Chemicell markets and manufactures a variety of magnetic nano- and microparticles (including the fluidMAG platform) used for diagnostic, research, and gene transfection applications, supporting workflows in cell labeling, gene delivery, and molecular biology[1][4][7]. Its products are widely adopted for lab automation and high-throughput applications in biosciences.

Modalities: NanoparticleMagnetic nanoparticleMicrobeadFluorescent microsphere
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Chemicell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemicell.

Explore the full profile